NEURORADIOLOGY / ORIGINAL PAPER
High-grade gliomas associated with neurofibromatosis type 1: analysis of imaging features and literature review
More details
Hide details
1
Department of Radiodiagnosis, Tata Memorial Centre, Mumbai, India
2
Homi Bhabha National Institute, Mumbai, India
3
Department of Radiation Oncology, Tata Memorial Centre, Mumbai, India
4
Department of Pathology, Tata Memorial Centre, Mumbai, India
5
Advanced Centre for Treatment, Education and Research in Cancer, Navi Mumbai, India
6
Department of Paediatric Oncology, Tata Memorial Centre, Mumbai, India
7
Department of Neurosurgery, Tata Memorial Centre, Mumbai, India
Submission date: 2025-02-02
Final revision date: 2025-05-18
Acceptance date: 2025-06-10
Publication date: 2025-09-12
Corresponding author
Arpita Sahu
Department of Radiodiagnosis, Tata Memorial Centre, Mumbai, India
Pol J Radiol, 2025; 90: 458-464
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Neurofibromatosis type 1 (NF-1) is an autosomal dominant genetic disorder notably linked to the development of central nervous system neoplasms – predominantly low-grade glial tumours like pilocytic astrocytoma. High-grade glial neoplasms (HGG) are rarer and more prevalent in adults, with very few comprehensive studies on imaging features of the same. This study aims to investigate the imaging characteristics of HGG in patients with NF-1, to identify alarming imaging features that potentially indicate higher-grade tumours.
Material and methods:
Conducting a retrospective analysis, we examined histologically confirmed cases of HGG within clinically diagnosed NF-1 patients over 8 years. Our analysis scrutinised various imaging parameters, and histopathological and molecular data.
Results:
Eight cases of NF-1-associated HGG were identified. Predominant features included large tumour size (> 5 cm) in most (77.8%), intra-tumoral necrosis (77.8%), and moderate to marked perilesional oedema (55.55%). Notably, more than half were centred in midline structures. Molecular analysis highlighted diverse statuses of ATRX, IDH1R132H, and P53.
Conclusions:
This retrospective analysis of the largest single-centre dataset on imaging of HGG in NF-1 patients reported in the literature underscores that it may be more common than previously surmised. The need to look for alarming imaging indicators and raise suspicion in atypical locations like midline structures is essential for early detection and appropriate treatment.
REFERENCES (21)
1.
Wang MX, Dillman JR, Guccione J, Habiba A, Maher M, Kamel S, et al. Neurofibromatosis from head to toe: what the radiologist needs to know. Radiographics 2022; 42: 1123-1144.
2.
Rekha A, Sanoop AVM, Das S, Chapla A, Srinageshwari B, Barney A,et al. Clinical and molecular profile of neurofibromatosis type 1 patients using revised diagnostic criteria – a retrospective cohort study. Neurology India 2024; 72: 1174. DOI: 10.4103/ni.ni_744_22.
3.
Fisher MJ, Jones DTW, Li Y, Guo X, Sonawane PS, Waanders AJ, et al. Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1). Acta Neuropathol 2021; 141: 605-617.
4.
Costa ADA, Gutmann DH. Brain tumors in neurofibromatosis type 1. Neurooncol Adv 2019; 1: vdz040. DOI: 10.1093/noajnl/vdz040.
5.
Narasimhaiah D, Sridutt BS, Thomas B, Vilanilam GC. Glioblastoma in adults with neurofibromatosis type I: a report of two cases. Neuropathology 2019; 39: 368-373.
6.
Legius E, Messiaen L, Wolkenstein P, Pancza P, Avery RA, Berman Y, et al. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med 2021; 23: 1506-1513.
7.
Listernick R, Charrow J, Gutmann DH. Intracranial gliomas in neurofibromatosis type 1. Am J Med Genet 1999; 89: 38-44.
8.
Listernick R, Louis DN, Packer RJ, Gutmann DH. Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol 1997; 41: 143-149.
9.
Albers AC, Gutmann DH. Gliomas in patients with neurofibromatosis type 1. Expert Rev Neurother 2009; 9: 535-539.
10.
Lobbous M, Bernstock JD, Coffee E, Friedman GK, Metrock LK, Chagoya G, et al. An update on neurofibromatosis type 1-associated gliomas. Cancers (Basel) 2020; 12: 114. DOI: 10.3390/cancers-12010114.
11.
Rosser T, Packer RJ. Intracranial neoplasms in children with neurofibromatosis 1. J Child Neurol 2002; 17: 630-637; discussion 646-651.
12.
Rodriguez FJ, Perry A, Gutmann DH, O’Neill BP, Leonard J, Bryant S, et al. Gliomas in neurofibromatosis type 1: a clinicopathologic study of 100 patients. J Neuropathol Exp Neurol 2008; 67: 240-249.
13.
Spyris CD, Castellino RC, Schniederjan MJ, Kadom N. High-grade gliomas in children with neurofibromatosis type 1: literature review and illustrative cases. AJNR Am J Neuroradiol 2019; 40: 366-369.
14.
Landry JP, Schertz KL, Chiang YJ, Bhalla AD, Yi M, Keung EZ, et al. Comparison of cancer prevalence in patients with neurofibromatosis type 1 at an academic cancer center vs in the general population from 1985 to 2020. JAMA Network Open 2021; 4: e210945. DOI: 10.1001/jamanetworkopen.2021.0945.
15.
Schreck KC, Ranjan S, Skorupan N, Bettegowda C, Eberhart CG, Ames HM, et al. Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas. J Neurooncol 2019; 143: 87-93.
16.
Dono A, Takayasu T, Ballester LY, Esquenazi Y. Adult diffuse midline gliomas: clinical, radiological, and genetic characteristics. J Clin Neurosci 2020; 82(Pt A): 1-8.
17.
Garibotto F, Madia F, Milanaccio C, Verrico A, Piccardo A, Tortora D, et al. Pediatric diffuse midline gliomas H3 K27M-mutant and non-histone mutant midline high-grade gliomas in neurofibromatosis type 1 in comparison with non-syndromic children: a singlecenter pilot study. Front Oncol 2020; 10: 795. DOI: 10.3389/fonc.2020.00795.
18.
Cho SK, Na DG, Ryoo JW, Roh HG, Moon CH, Byun HS, et al. Perfusion MR imaging: clinical utility for the differential diagnosis of various brain tumors. Korean J Radiol 2002; 3: 171-179.
19.
D’Angelo F, Ceccarelli M, Tala null, Garofano L, Zhang J, Frattini V, et al. The molecular landscape of glioma in patients with neurofibromatosis 1. Nat Med 2019; 25: 176-187.
20.
Tamrazi B, Mankad K, Nelson M, D’Arco F. Current concepts and challenges in the radiologic assessment of brain tumors in children: part 2. Pediatr Radiol 2018; 48: 1844-1860.
21.
Lucas CHG, Sloan EA, Gupta R, Wu J, Pratt D, Vasudevan HN, et al. Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. Acta Neuropathol 2022; 144: 747-765.